Payment overview · 2025
General Payments
$140.13
1 reported records · 1 companies
Healthcare provider profile · identity verified
Destiny Etheridge, MD
Allopathic & Osteopathic Physicians|Family Medicine · INDIANAPOLIS, IN · NPI 1871099002
Verified facts
What the public records show
CMS Open Payments records show Destiny Etheridge, MD received $140.13 in general payments during 2025 across 1 reported records.
Edwards Lifesciences Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Edwards Lifesciences Corporation | Unresolved — no canonical attribution shown | $140.13 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $140.13 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SAPIEN 3 Ultra RESILIA Normalized: sapien 3 ultra resilia |
Device | Edwards Lifesciences Corporation | $140.13 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 648 | 199 |
| Atorvastatin Calcium | Atorvastatin Calcium | 524 | 161 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 374 | 103 |
| Potassium Chloride | Potassium Chloride | 288 | 74 |
| Gabapentin | Gabapentin | 285 | 64 |
| Hydrochlorothiazide | Hydrochlorothiazide | 273 | 81 |
| Pantoprazole Sodium | Pantoprazole Sodium | 273 | 75 |
| Lisinopril | Lisinopril | 257 | 73 |
| Losartan Potassium | Losartan Potassium | 247 | 72 |
| Omeprazole | Omeprazole | 241 | 53 |
| Furosemide | Furosemide | 213 | 63 |
| Metoprolol Succinate | Metoprolol Succinate | 206 | 65 |
| Carvedilol | Carvedilol | 192 | 48 |
| Metformin Hcl | Metformin Hcl | 191 | 56 |
| Fluticasone Propionate | Fluticasone Propionate | 180 | 66 |
| Levothyroxine Sodium | Levothyroxine Sodium | 173 | 43 |
| Eliquis | Apixaban | 172 | 37 |
| Montelukast Sodium | Montelukast Sodium | 171 | 53 |
| Meloxicam | Meloxicam | 154 | 44 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 143 | 40 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 133 | 29 |
| Diclofenac Sodium | Diclofenac Sodium | 133 | 53 |
| Clopidogrel | Clopidogrel Bisulfate | 131 | 37 |
| Simvastatin | Simvastatin | 124 | 36 |
| Hydralazine Hcl | Hydralazine Hcl | 121 | 37 |
| Trazodone Hcl | Trazodone Hcl | 113 | 33 |
| Metoprolol Tartrate | Metoprolol Tartrate | 109 | 32 |
| Allopurinol | Allopurinol | 104 | 28 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 101 | 22 |
| Spironolactone | Spironolactone | 96 | 24 |
| Methocarbamol | Methocarbamol | 94 | 30 |
| Ozempic | Semaglutide | 92 | 19 |
| Tamsulosin Hcl | Tamsulosin Hcl | 91 | 24 |
| Tizanidine Hcl | Tizanidine Hcl | 91 | 32 |
| Duloxetine Hcl | Duloxetine Hcl | 89 | 25 |
| Mounjaro | Tirzepatide | 85 | 17 |
| Baclofen | Baclofen | 84 | 16 |
| Glipizide Er | Glipizide | 84 | 25 |
| Famotidine | Famotidine | 82 | 22 |
| Fluoxetine Hcl | Fluoxetine Hcl | 75 | 14 |
| Buspirone Hcl | Buspirone Hcl | 73 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 72 | 27 |
| Ezetimibe | Ezetimibe | 70 | 22 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 68 | 20 |
| Ibuprofen | Ibuprofen | 68 | 22 |
| Metformin Hcl Er | Metformin Hcl | 68 | 17 |
| Fluconazole | Fluconazole | 66 | 28 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 66 | 16 |
| Jardiance | Empagliflozin | 65 | 14 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 63 | 47 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 61 | 25 |
| Benazepril Hcl | Benazepril Hcl | 60 | 20 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 58 | 20 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 56 | 17 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 52 | 17 |
| Chlorthalidone | Chlorthalidone | 51 | 15 |
| Clonidine Hcl | Clonidine Hcl | 51 | 13 |
| Ondansetron Odt | Ondansetron | 51 | 27 |
| Prednisone | Prednisone | 49 | 31 |
| Quetiapine Fumarate | Quetiapine Fumarate | 47 | 16 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 46 | 13 |
| Donepezil Hcl | Donepezil Hcl | 46 | 14 |
| Alprazolam | Alprazolam | 45 | suppressed |
| Bumetanide | Bumetanide | 45 | 16 |
| Dicyclomine Hcl | Dicyclomine Hcl | 45 | suppressed |
| Naproxen | Naproxen | 45 | 13 |
| Estradiol | Estradiol | 44 | 11 |
| Januvia | Sitagliptin Phosphate | 44 | 13 |
| Nifedipine Er | Nifedipine | 44 | 14 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 44 | 15 |
| Amitriptyline Hcl | Amitriptyline Hcl | 43 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 42 | 13 |
| Levetiracetam | Levetiracetam | 42 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 41 | 15 |
| Alendronate Sodium | Alendronate Sodium | 40 | 12 |
| Pregabalin | Pregabalin | 40 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 39 | 13 |
| Tramadol Hcl | Tramadol Hcl | 39 | 15 |
| Promethazine Hcl | Promethazine Hcl | 38 | 11 |
| Azithromycin | Azithromycin | 37 | 36 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 36 | 18 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 36 | 14 |
| Rybelsus | Semaglutide | 36 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 35 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 35 | 12 |
| Trulicity | Dulaglutide | 35 | suppressed |
| Verapamil Er | Verapamil Hcl | 35 | 11 |
| Nystatin | Nystatin | 34 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 34 | 11 |
| Farxiga | Dapagliflozin Propanediol | 33 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 33 | 15 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 33 | 22 |
| Linzess | Linaclotide | 33 | 15 |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 32 | suppressed |
| Olanzapine | Olanzapine | 31 | suppressed |
| Aripiprazole | Aripiprazole | 30 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 30 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 30 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 29 | 21 |
| Topiramate | Topiramate | 29 | suppressed |
| Clonazepam | Clonazepam | 28 | suppressed |
| Lidocaine | Lidocaine | 28 | suppressed |
| Glimepiride | Glimepiride | 26 | suppressed |
| Indapamide | Indapamide | 26 | suppressed |
| Gemfibrozil | Gemfibrozil | 25 | suppressed |
| Myrbetriq | Mirabegron | 25 | suppressed |
| Xarelto | Rivaroxaban | 25 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 24 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 24 | suppressed |
| Hydrocortisone | Hydrocortisone | 24 | 17 |
| Bupropion Xl | Bupropion Hcl | 23 | suppressed |
| Methylprednisolone | Methylprednisolone | 23 | 20 |
| Valacyclovir | Valacyclovir Hcl | 23 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 22 | 20 |
| Glipizide | Glipizide | 22 | suppressed |
| Klor-Con M20 | Potassium Chloride | 22 | suppressed |
| Sucralfate | Sucralfate | 22 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 21 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 21 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 20 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 20 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 20 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 19 | suppressed |
| Ketoconazole | Ketoconazole | 19 | suppressed |
| Valsartan | Valsartan | 19 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 18 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 17 | suppressed |
| Colchicine | Colchicine | 17 | suppressed |
| Digoxin | Digoxin | 17 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 17 | suppressed |
| Metronidazole | Metronidazole | 17 | 13 |
| Mirtazapine | Mirtazapine | 17 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 16 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Nitroglycerin | Nitroglycerin | 16 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 15 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 15 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 15 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 14 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Finasteride | Finasteride | 14 | suppressed |
| Risperidone | Risperidone | 14 | suppressed |
| Suboxone | Buprenorphine Hcl/Naloxone Hcl | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Atenolol | Atenolol | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 13 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 13 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 13 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 13 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Clonidine | Clonidine | 12 | suppressed |
| Creon | Lipase/Protease/Amylase | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 12 | suppressed |
| Felodipine Er | Felodipine | 12 | suppressed |
| Guanfacine Hcl | Guanfacine Hcl | 12 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Klor-Con M10 | Potassium Chloride | 12 | suppressed |
| Lorazepam | Lorazepam | 12 | suppressed |
| Memantine Hcl | Memantine Hcl | 12 | suppressed |
| Amoxicillin | Amoxicillin | 11 | suppressed |
| Diazepam | Diazepam | 11 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 11 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $140.13 · 1 records | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error